Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07039487

EVALUATION OF NEUTROPHIL FLUORESCENCE IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH SEPTIC SHOCK

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Neutrophil fluorescence could be a reliable and early diagnostic marker of disseminated intravascular coagulation septic DIC, which can be used routinely. The objective of the investigators is to define the optimal threshold of neutrophil fluorescence associated with a sensitivity of at least 90% for the diagnosis of DIC.

Conditions

Interventions

TypeNameDescription
OTHERBlood sampling collectionCBC performed on the background of an EDTA tube, collected routinely allowing neutrophil fluorescence measurements. This tube will then be passed over on the automaton for a CBC measurement with leukocyte differentiation.

Timeline

Start date
2025-07-01
Primary completion
2027-07-01
Completion
2027-08-01
First posted
2025-06-26
Last updated
2025-06-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07039487. Inclusion in this directory is not an endorsement.